Compare OVV & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVV | ASND |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0B | 15.0B |
| IPO Year | 2019 | 2014 |
| Metric | OVV | ASND |
|---|---|---|
| Price | $72.44 | $243.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 27 | 21 |
| Target Price | $78.29 | ★ $306.03 |
| AVG Volume (30 Days) | ★ 3.0M | 683.6K |
| Earning Date | 11-03-2026 | 11-11-2026 |
| Dividend Yield | ★ 1.73% | N/A |
| EPS Growth | ★ 13.54 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,908,000,000.00 | N/A |
| Revenue This Year | $15.11 | $90.81 |
| Revenue Next Year | N/A | $46.89 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $35.47 | $188.07 |
| 52 Week High | $70.98 | $282.15 |
| Indicator | OVV | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 74.38 | 59.41 |
| Support Level | $57.34 | $242.17 |
| Resistance Level | N/A | $249.89 |
| Average True Range (ATR) | 1.82 | 6.21 |
| MACD | 0.85 | 2.90 |
| Stochastic Oscillator | 95.03 | 97.35 |
Ovintiv Inc is a North American oil and natural gas exploration and production company focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs, and natural gas. The company has two operating segments: USA Operations and Canadian Operations. USA Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within the United States. Canadian Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within Canada. The company generates the majority of its revenue from USA Operations.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.